Human adipose tissue-derived stem cells protect impaired cardiomyocytes from hypoxia/reoxygenation injury through hypoxia-induced paracrine mechanism

Cell Biochemistry and Function

Volumn 30, Issue 6, 2012, Pages 505-514

  Yang, Junjie ^a   Zhang, Huaxin ^a   Zhao, Liang ^b   Chen, Yundai ^a   Liu, Hongbin ^a   Zhang, Tao ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Cardiomyocyte injury; Human adipose derived stem cell; JNK signal pathway; Myocardial infarction; Paracrine

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CASPASE 3; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 1; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CELL HYPOXIA; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; HUMAN CELL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; NEWBORN; NICK END LABELING; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; RAT; REOXYGENATION; STEM CELL;

ADIPOSE TISSUE; ANTHRACENES; CELL HYPOXIA; CELLS, CULTURED; CYTOPROTECTION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MYOCYTES, CARDIAC; OXYGEN; PARACRINE COMMUNICATION; STEM CELLS;

EID: 84865351105     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2829     Document Type: Article

References (32)

1. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature 2008; 451: 937-942.
2. Palpant NJ, Metzger JM. Aesthetic cardiology: adipose-derived stem cells for myocardial repair. Curr Stem Cell Res Ther 2010; 5: 145-152.
3. Gnecchi M, Zhang Z, Ni A, et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008; 103: 1204-1219.
4. Gnecchi M, He H, Liang OD, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005; 11: 367-368.
5. Hu X, Yu SP, Fraser JL, et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 2008; 135: 799-808.
6. Psaltis PJ, Zannettino AC, Worthley SG, et al. Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells 2008; 26: 2201-2210.
7. Kinnaird T, Stabile E, Burnett MS, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004; 94: 678-685.
8. Xu RX, Chen X, Chen JH, et al. Mesenchymal stem cells promote cardiomyocyte hypertrophy in vitro through hypoxia-induced paracrine mechanisms. Clin Exp Pharmacol Physiol 2009; 36: 176-180.
9. Takahashi M, Li TS, Suzuki R, et al. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol 2006; 291: H886-893.
10. Kim WS, Park BS, Kim HK, et al. Evidence supporting antioxidant action of adipose-derived stem cells: protection of human dermal fibroblasts from oxidative stress. J Dermatol Sci 2008; 49: 133-142.
11. Tsuruta F, Sunayama J, Mori Y, et al. JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J 2004; 23: 1889-1899.
12. Hreniuk D, Garay M, Gaarde W, et al. Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes. Mol Pharmacol 2001; 59: 867-874.
13. Andreka P, Zang J, Dougherty C, et al. Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis. Circ Res 2001; 88: 305-312.
14. Kim YS, Ahn Y, Hong MH, et al. Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells. J Cardiovasc Pharmacol 2007; 49: 376-383.
15. Locke M, Windsor J, Dunbar PR. Human adipose-derived stem cells: isolation, characterization and applications in surgery. ANZ J Surg 2009; 79: 235-244.
16. Bai X, Yan Y, Song YH, et al. Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur Heart J 2010; 31: 489-501.
17. Webster KA, Discher DJ, Kaiser S, et al. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J Clin Invest 1999; 104: 239-252.
18. Gersh BJ, Simari RD, Behfar A, et al. Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc 2009; 84: 876-892.
19. Kim Y, Kim H, Cho H, et al. Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem 2007; 20: 867-876.
20. Yu H, Li Q, Kolosov VP, et al. Regulation of cigarette smoke-mediated mucin expression by hypoxia-inducible factor-1alpha via epidermal growth factor receptor-mediated signaling pathways. J Appl Toxicol 2011; 32: 282-292.
21. Zachar V, Duroux M, Emmersen J, et al. Hypoxia and adipose-derived stem cell-based tissue regeneration and engineering. Expert Opin Biol Ther 2011; 11: 775-786.
22. Ikeuchi M, Tsutsui H, Shiomi T, et al. Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Cardiovasc Res 2004; 64: 526-535.
23. Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004; 109: 1292-1298.
24. Laderoute KR, Webster KA. Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes. Circ Res 1997; 80: 336-344.
25. Kubasiak LA, Hernandez OM, Bishopric NH, et al. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc Natl Acad Sci U S A 2002; 99: 12825-12830.
26. Chao W, Shen Y, Li L, et al. Importance of FADD signaling in serum deprivation- and hypoxia-induced cardiomyocyte apoptosis. J Biol Chem 2002; 277: 31639-31645.
27. Dougherty CJ, Kubasiak LA, Frazier DP, et al. Mitochondrial signals initiate the activation of c-Jun N-terminal kinase (JNK) by hypoxia-reoxygenation. FASEB J 2004; 18: 1060-1070.
28. Vaishnav D, Jambal P, Reusch JE, et al. SP600125, an inhibitor of c-jun N-terminal kinase, activates CREB by a p38 MAPK-mediated pathway. Biochem Biophys Res Commun 2003; 307: 855-860.
29. Sze SK, de Kleijn DP, Lai RC, et al. Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics 2007; 6: 1680-1689.
30. Engelbrecht AM, Niesler C, Page C, et al. p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes. Basic Res Cardiol 2004; 99: 338-350.
31. Shao Z, Bhattacharya K, Hsich E, et al. c-Jun N-terminal kinases mediate reactivation of Akt and cardiomyocyte survival after hypoxic injury in vitro and in vivo. Circ Res 2006; 98: 111-118.
32. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007; 357: 1121-1135.